Our Research

Data-driven insights are the foundation for all we do. Grounded in cutting-edge clinical science and 10 years of research from The University of Oxford, our solutions are at the forefront of neurological care. We are dedicated to bringing together the best evidence for the advancement of care in Parkinson's Disease and Dementia. Below is a selection of some of our peer reviewed academic publications:

Parkinson’s Disease

1. Predicting motor, cognitive & functional impairment in Parkinson's Disease.

This study, in the Annals of Clinical Translational Neurology, delves into predictive models for Parkinson’s Disease progression. It highlights the criticality of accurate measurement and our ability to predict key future clinical outcomes. Read more

2. A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s Disease.

Featured in the Journal of Neurology, Neurosurgery, and Psychiatry, this study introduces a novel composite clinical score that can be used for monitoring Parkinson's Disease progression and refining patient care. Read more

3. Smartphone motor testing to distinguish idiopathic Rapid Eye Movement sleep behavior disorder, controls, and Parkinson’s Disease.

A study in Neurology, the prestigious journal from the American Academy Neurology, demonstrates our smartphone-based motor testing's efficacy. Our platform can successfully differentiate idiopathic REM sleep behaviour disorder, Parkinson's Disease, and age matched control groups, showcasing the potential of our digital tools. Read more

4. Smartphone Speech Testing for Symptom Assessment in Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease

Published in IEEE Access, this research on smartphone speech testing marks a significant stride in symptom assessment and diagnostic ability for REM Sleep Behavior Disorder and Parkinson's Disease using voice analysis. Read more

Dementia

1. Visual short-term memory binding deficit in familial Alzheimer's Disease.

Published in Cortex, this research validates the effectiveness of our cognitive tasks in assessing various cognitive functions, vital for assessing Alzheimer's progression. Read more

2. Different patterns of short-term memory deficit in Alzheimer's Disease, Parkinson's Disease and subjective cognitive impairment.

This publication in Cortex, demonstrates how our measure of memory precision can provides an easy-to-administer assessment of short-term memory that is sensitive to the different types of deficit in Alzheimer’s Disease and Parkinson’s Disease, with the ability to inform clinical practice. Read more

3. Short-term memory advantage for brief durations in human APOE ε4 carriers

This study in Nature Scientific Reports further supports the role of cognitive tasks in Alzheimer's Disease and those with genetic risk factors for the condition, offering deeper insights into the disease's genetic complexity assessment methods. Read more

Neu Health is built on research and continued collaboration with Oxford University. We are continually developing new studies and publications to enhance the precision of our methods and strengthening our commitment to innovative neurological management solutions.